New York, NY
Ezra has created a new way to screen for cancer using full-body MRI technology assisted by Artificial Intelligence. The company's first AI, developed to assist radiologists when interpreting MRI images of the prostate, is an FDA-cleared software as a medical device.
ezra.comThese are collections Ezra is a part of. Click on the collection name to view similar companies.
Series B
$21,000,000
Series A
$18,000,000
Seed
$4,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Ezra.